Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-26

Clinical Trial Update: Study to Assess the Efficacy of Liraglutide in Patients With Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating liraglutide for Type 2 Diabetes mellitus has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • liraglutide (liraglutide)

Snippet

Sponsor: Lecube, Albert, M.D. | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2021-02-26